Back to Journals » Journal of Blood Medicine » Volume 10

Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC)

Total article views   HTML views PDF downloads Totals
14,419 Dovepress* 13,050+ 2,045 15,095
PubMed Central* 1,369 320 1,689
Totals 14,419 2,365 16,784
*Since 18 September 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar